Lysozyme

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Summary

Lysozyme is an enzyme indicated in the treatment of gastrointestinal disorders in infants, as well as Herpes zoster and Herpes simplex.

Generic Name
Lysozyme
DrugBank Accession Number
DB13260
Background

Not Available

Type
Biotech
Groups
Experimental, Investigational
Biologic Classification
Protein Based Therapies
Other protein based therapies
Protein Chemical Formula
Not Available
Protein Average Weight
Not Available
Sequences
Not Available
Synonyms
Not Available
External IDs
  • E-1105
  • INS NO.1105
  • INS-1105

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Indication TypeIndicationCombined Product DetailsApproval LevelAge GroupPatient CharacteristicsDose Form
Adjunct therapy in treatment ofGastrointestinal symptoms••••••••••••••••••••••••
Adjunct therapy in treatment ofHerpes simplex••••••••••••••••••
Adjunct therapy in treatment ofHerpes zoster••••••••••••••••••
Used in combination for symptomatic treatment ofMouth ulcersCombination Product in combination with: Pyridoxine (DB00165)•••••••••••••••••••
Used in combination for symptomatic treatment ofOrofacial painCombination Product in combination with: Pyridoxine (DB00165)•••••••••••••••••••
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Product Ingredients
IngredientUNIICASInChI Key
Lysozyme chloride4YRW73H69V9066-59-5Not applicable
International/Other Brands
Delvozyme
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
E-zyme SyrupSyrupOralAV MANUFACTURING SDN.BHD2020-09-08Not applicableMalaysia flag
E-zyme SyrupSyrup25 mg/5mlOralAV MANUFACTURING SDN.BHD2016-12-222019-01-09Malaysia flag
E-zyme trocheTablet, orally disintegrating200 mgOralAV MANUFACTURING SDN.BHD2016-12-222019-01-09Malaysia flag
E-zyme TrocheTablet, orally disintegratingOralAV MANUFACTURING SDN.BHD2020-09-08Not applicableMalaysia flag
Leftose 30mg TabletTablet, orally disintegratingOralULTRAVITE SDN BHD2020-09-08Not applicableMalaysia flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
E-zyme B6 Soothing LiquidLysozyme chloride (20 mg/5ml) + Pyridoxine hydrochloride (10 mg/5ml)LiquidOralAV MANUFACTURING SDN.BHD2020-09-08Not applicableMalaysia flag
E-zyme B6 TrocheLysozyme chloride (80 mg) + Pyridoxine hydrochloride (40 mg)Tablet, orally disintegratingOralAV MANUFACTURING SDN.BHD2020-09-08Not applicableMalaysia flag
Lyso-B LozengesLysozyme chloride (80 mg) + Pyridoxine hydrochloride (40 mg)LozengeOralAdvance Pharma Sdn Bhd2020-09-08Not applicableMalaysia flag
Lyso-B Oral LiquidLysozyme chloride (20 mg/5ml) + Pyridoxine hydrochloride (10 mg/5ml)LiquidOralAdvance Pharma Sdn Bhd2020-09-08Not applicableMalaysia flag
LYSOBACT 20 MG/10 MG PASTİL, 30 ADETLysozyme chloride (20 mg) + Pyridoxine hydrochloride (10 mg)LozengeOralENFARMA İLAÇ SAN. VE TİC. LTD. ŞTİ.2020-08-14Not applicableTurkey flag

Categories

ATC Codes
J05AX02 — LysozymeD06BB07 — Lysozyme
Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
Not Available
Kingdom
Organic Compounds
Super Class
Organic Acids
Class
Carboxylic Acids and Derivatives
Sub Class
Amino Acids, Peptides, and Analogues
Direct Parent
Peptides
Alternative Parents
Not Available
Substituents
Not Available
Molecular Framework
Not Available
External Descriptors
Not Available
Affected organisms
Not Available

Chemical Identifiers

UNII
968JKA7T33
CAS number
12650-88-3

References

General References
  1. AIFA Product Information: Lisozima Spa (lysozyme hydrochloride) oral tablets [Link]
RxNav
7094
Wikipedia
Lysozyme

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4CompletedTreatmentAsthma / Chronic Obstructive Pulmonary Disease (COPD)1
4CompletedTreatmentChronic Obstructive Pulmonary Disease (COPD)1
3CompletedSupportive CareDry Mouth1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Tablet, orally disintegratingOral
SyrupOral25 mg/5ml
Tablet, orally disintegratingOral200 mg
TabletOral
Tablet, orally disintegratingOral
SyrupOral
TabletOral30 mg
TabletOral10 MG
TabletOral100 MG
TabletOral2 MG
TabletOral250 MG
TabletOral500 MG
LiquidOral
LozengeOral
TabletOral90 mg
SyrupOral5 mg/ml
Capsule
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at June 23, 2017 20:38 / Updated at June 05, 2021 09:13